We propose a hybrid two-group classification method that integrates linear discriminant analysis, a polynomial expansion of the basis (or variable space), and a genetic algorithm with multiple crossover operations to select variables from the expanded basis. Using new product launch data from the biochemical industry, we found that the proposed algorithm offers mean percentage decreases in the misclassification error rate of 50%, 56%, 59%, 77%, and 78% in comparison to a support vector machine, artificial neural network, quadratic discriminant analysis, linear discriminant analysis, and logistic regression, respectively. These improvements correspond to annual cost savings of $4.40–$25.73 million.
No takes yet. Share an insight, caveat, or question.
Brusco et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: